Line 140: | Line 140: | ||
</div> | </div> | ||
<div class="wcontent_alt"> | <div class="wcontent_alt"> | ||
− | <a href="" ng-click="active='Gal1-CFP NSC'">Gal1-CFP NSC</a> | + | <a href="" ng-click="active='Gal1-CFP-NSC'">Gal1-CFP NSC</a> |
</div> | </div> | ||
<div class="wcontent_alt"> | <div class="wcontent_alt"> | ||
Line 247: | Line 247: | ||
<img src="https://static.igem.org/mediawiki/2016/c/c0/T--Waterloo--Gal1_GFP.png" class="wcontent-img-solo37"> | <img src="https://static.igem.org/mediawiki/2016/c/c0/T--Waterloo--Gal1_GFP.png" class="wcontent-img-solo37"> | ||
<div class="wcontent-caption paragraph-medium"> | <div class="wcontent-caption paragraph-medium"> | ||
− | The | + | The Gal1 and GFP fusion. |
</div> | </div> | ||
</div> | </div> | ||
Line 261: | Line 261: | ||
<img src="https://static.igem.org/mediawiki/2016/0/0c/T--Waterloo--Cup1_GFP.png" class="wcontent-img-solo37"> | <img src="https://static.igem.org/mediawiki/2016/0/0c/T--Waterloo--Cup1_GFP.png" class="wcontent-img-solo37"> | ||
<div class="wcontent-caption paragraph-medium"> | <div class="wcontent-caption paragraph-medium"> | ||
− | The | + | The Cup1 and GFP fusion. |
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-lg-8"> | ||
+ | <div class="wcontent-box" id="Gal1-CFP-NSC" ng-show="active == 'Gal1-CFP-NSC'"> | ||
+ | <div class="wcontent-title"> | ||
+ | Gal1-CFP NSC | ||
+ | </div> | ||
+ | <div class="wcontent"> | ||
+ | <p class="paragraph-medium">This biobrick is a fusion of the Gal1,10 promoter, Cyan Fluorescent Protein (CFP), and the chaperone protein Hsp104.</p> | ||
+ | <img src="https://static.igem.org/mediawiki/2016/0/05/T--Waterloo--Gal1_CFP_NSC.png" class="wcontent-img-solo37"> | ||
+ | <div class="wcontent-caption paragraph-medium"> | ||
+ | The Gal1, CFP, and Hsp104 fusion. | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 20:33, 15 October 2016
This construct is a control to test the metabolic load of the Hsp104-CFP fusion protein and as a baseline against which we compare the change in [PSI+]/[psi-] state. We synthesized a fragment to clone into the [Hsp-PRS315]. This plasmid will be referred to as the Hsp104 plasmid and is used in several of our experiments.
CFP was synthesized with a stop codon in the place of Tyr-39 (TAC -> TAG) and amplified with flanking ApaI and BamHI sites. The premature stop codon (before the CFP fluorophore) was expected to truncate the protein during normal transcription. Fluorimetry readings were then used to quantify the amount of read-through for the CFP-tagged Hsp104.
CFP was synthesized with a stop codon in the place of Val-22 (TCA -> TAG) and amplified with flanking ApaI and BamHI sites. The premature stop codon (before the CFP fluorophore) was expected to truncate the protein during normal transcription. Fluorimetry readings were then used to quantify the amount of read-through for the CFP-tagged Hsp104.
This biobrick contains a fusion of the ADH1 promoter and GFP. ADH1 is a eukaryotic promoter; the presence of ethanol induces it. The fusion between it and GFP allows the strength of the promoter to be quantized in varying concentrations of ethanol using the fluorescence of the GFP.
This biobrick is a fusion of the Gal1 promoter and GFP protein. Gal1 is a eukaryotic promoter; the presence of galactose induces it. The fusion allows the strength of the promoter to be quantized in the presence of varying concentrations of galactose using the fluorescence of the GFP.
This biobrick is a fusion of the Cup1 promoter and GFP protein. Cup1 is a eukaryotic promoter; the presence of Cu2+ induces it. The fusion allows the strength of the promoter to be quantized in the presence of varying concentrations of copper ions using the fluorescence of the GFP.
This biobrick is a fusion of the Gal1,10 promoter, Cyan Fluorescent Protein (CFP), and the chaperone protein Hsp104.